|
Volumn 65, Issue 2, 2011, Pages
|
Treatment of recalcitrant vulvovaginal gingival syndrome with adalimumab
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
CIPROFLOXACIN PLUS DEXAMETHASONE;
CLOBETASOL;
ETRETIN;
FLUTICASONE;
HEPATITIS C ANTIBODY;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN G ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
TUMOR NECROSIS FACTOR ALPHA;
ABSENCE OF SIDE EFFECTS;
AGED;
APHTHOUS ULCER;
BIOPSY;
BLOOD CELL COUNT;
CASE REPORT;
CLINICAL ASSESSMENT;
COMPLEX APHTHOSIS;
DIFFERENTIAL DIAGNOSIS;
DRUG WITHDRAWAL;
FEMALE;
HEADACHE;
HEART BEAT;
HISTOPATHOLOGY;
HUMAN;
HYPERKERATOSIS;
HYPERPLASIA;
LETTER;
LICHENOID ERUPTION;
LICHENOID LYMPHOCYTIC INFILTRATE;
LIVER FUNCTION TEST;
LYMPHOCYTIC INFILTRATION;
MOUTH ULCER;
PARAKERATOSIS;
PHOTOTOXICITY;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RECALCITRANT VULVOVAGINAL GINGIVAL SYNDROME;
SIDE EFFECT;
SPONGIOSIS;
SQUAMOUS CELL;
THYROID FUNCTION TEST;
TREATMENT DURATION;
TREATMENT FAILURE;
TREATMENT RESPONSE;
ULCER;
VAGINA DISEASE;
VULVA BIOPSY;
VULVA ULCER;
VULVOVAGINAL DISEASE;
|
EID: 79960400154
PISSN: 01909622
EISSN: 10976787
Source Type: Journal
DOI: 10.1016/j.jaad.2010.10.034 Document Type: Article |
Times cited : (7)
|
References (4)
|